USPTO granted Medtronic, Inc. Patent US12592382B2 for electrochemical cells featuring lithium alloy anodes and methods for preventing thermal runaway. The anode composition comprises 70-99 weight percent lithium and includes a fault-responsive mechanism to reduce maximum ion transfer rates between electrodes. The patent has 18 claims and classifications spanning H01M (batteries) and A61N (medical implants), indicating applicability to implantable medical devices.

This is a patent grant rather than a regulatory action imposing compliance obligations. No immediate action is required by other entities. Competitors developing similar battery technologies should review this patent to assess potential freedom-to-operate implications or licensing needs. Medtronic may leverage this IP portfolio for medical devices requiring safe, high-energy-density power sources such as pacemakers or neurostimulators.